Target intelligence / Profile preview

Physical X-ray attenuation via iodine content

Molecular classification
Other (Physical property; not a molecular family or biological classification)
01

Overview

“Physical X-ray attenuation via iodine content” describes the principle that iodine, owing to its high atomic number (53) and K-shell binding energy (33.2 keV), strongly absorbs X-rays at energies typical for diagnostic imaging[1][4][5]. This property is harnessed in clinical practice by formulating iodinated contrast agents, which, when introduced into the body, markedly increase the absorption of X-rays in tissues where they accumulate, improving image contrast and enabling visualization of vascular structures, organs, or pathological changes[1][5][8]. Iodine’s attenuation characteristics are strictly physical (photoelectric effect, K-edge absorption) and not due to a biological or molecular-specific target. Use of this phenomenon is central to CT, angiography, and a variety of radiological techniques. However, the reliance on iodine for contrast introduces secondary concerns, such as potential nephrotoxicity or rare, delayed DNA/radiation damage mediated by the increased local radiation dose[3][5].

Other names
Iodine-based X-ray attenuationIodine-enhanced attenuationX-ray contrast via iodineIodinated contrast attenuation
02

Mechanism of action

Increases absorption of X-rays through the photoelectric effect, due to the high atomic number of iodine (Z = 53) K-edge absorption at 33.2 keV, leading to strong attenuation at diagnostic imaging energies

03

Biological functions

Enhances radiographic image contrast (through physical X-ray attenuation)
04

Disease associations

Other (Used for diagnostics in cancer, cardiovascular disease, infection, etc., via imaging — but not a therapeutic target itself)
05

Safety considerations

Risks of iodinated contrast media (not the attenuation itself but the agents): nephrotoxicity (contrast-induced nephropathy)hypersensitivity or allergic reactionsrisk of increased local radiation dose leading to potential DNA damage and possible cancer risk

Beyond the preview

Go deeper on Physical X-ray attenuation via iodine content.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physical X-ray attenuation via iodine content.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call